MedVital has secured ₹18 Crore In Growth Funding led by Alkemi Growth Caipital, with participation from Dr. Sanjay Arora, Shubhan Ventures, and existing investors, as the company accelerates its expansion in advanced wound care and regenerative healthcare technologies.
Founded in 2024, MedVital focuses on developing Medical Technologies For Skin Repair, Wound Healing, Regenerative Aesthetics, And Chronic Dermatological Conditions. The company plans to use the fresh capital to scale operations, strengthen product development, and expand capabilities across Devices, Biomaterials, And Biologics.
A major growth driver for the company is its NoWound portfolio, which includes advanced wound care solutions such as Negative Pressure Wound Therapy (NPWT) systems and a chitosan based liquid bandage designed for hospital environments. These products have already gained adoption across 200+ Healthcare Institutions In India, reflecting increasing demand for advanced wound management solutions.
In addition to wound care, MedVital has entered the regenerative aesthetics segment through its Elyara product line, which focuses on Non-Invasive Skin And Hair Restoration Therapies powered by peptide led regenerative technologies.
The funding comes amid growing investor interest in India’s medtech and regenerative healthcare sector, where startups are increasingly building solutions around Precision Care, Chronic Disease Management, And Recovery Focused Technologies. Industry experts believe wound care remains a significantly underserved segment in India, creating strong opportunities for innovation and adoption.
Investors highlighted MedVital’s strong early clinical traction, disciplined execution, and hospital adoption as key reasons behind the investment. The company is now focused on expanding its footprint across hospitals while investing further in Clinical Education, Regulatory Readiness, And Evidence Based adoption.
With increasing cases of diabetes, chronic wounds, and skin related disorders in India, the demand for advanced regenerative and wound care solutions is expected to rise sharply over the coming years. Experts see MedVital’s expansion as part of a broader shift toward Technology Enabled Regenerative Healthcare in the country.
“Skin, the body’s largest organ, is increasingly impacted by ageing, diabetes, and chronic dermatological conditions yet access to innovative technologies remains limited.”
By
HB Team
